298
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Changes in liver and kidney function, red blood cell count and hemoglobin levels 1 day after ultrasound-guided percutaneous microwave ablation for uterine fibroids

, , , &
Article: 2338542 | Received 14 Dec 2023, Accepted 31 Mar 2024, Published online: 29 Apr 2024

Reference

  • Kim-Fuchs C, Candinas D, Lachenmayer A. The role of conventional and stereotactic microwave ablation for intrahepatic cholangiocarcinoma. J Clin Med. 2021;10(13):1. doi: 10.3390/jcm10132963.
  • Hui TC, Kwan J, Pua U. Advanced techniques in the percutaneous ablation of liver tumours. Diagnostics (Basel). 2021;11(4):585. doi: 10.3390/diagnostics11040585.
  • Ren C, Liang P, Yu XL, et al. Percutaneous microwave ablation of adrenal tumours under ultrasound guidance in 33 patients with 35 tumours: a single-centre experience. Int J Hyperthermia. 2016;32(5):517–7. doi: 10.3109/02656736.2016.1164905.
  • Lee JS, Hong GY, Lee KH, et al. Safety and efficacy of ultrasound-guided High-Intensity focused ultrasound treatment for uterine fibroids and Adenomyosis. Ultrasound Med Biol. 2019;45(12):3214–3221. doi: 10.1016/j.ultrasmedbio.2019.08.022.
  • Yang Y, Hao Y, Zhang J, et al. Ultrasound-guided percutaneous microwave ablation for subserosal uterine myomas. J Minim Invasive Gynecol. 2019;26(3):544–550. doi: 10.1016/j.jmig.2018.06.014.
  • Jeng CJ, Ou KY, Long CY, et al. 500 cases of high-intensity focused ultrasound (HIFU) ablated uterine fibroids and adenomyosis. Taiwan J Obstet Gynecol. 2020;59(6):865–871. doi: 10.1016/j.tjog.2020.09.013.
  • Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676. doi: 10.1016/j.ultsonch.2015.05.031.
  • Liu F, Yu X, Liang P, et al. Ultrasonography-guided percutaneous microwave ablation for large hepatic cavernous haemangiomas. Int J Hyperthermia. 2018;34(7):1061–1066. doi: 10.1080/02656736.2017.1392045.
  • Yang Y, Liu F, Yu J, et al. Risk factor analysis of acute kidney injury after microwave ablation of hepatocellular carcinoma: a retrospective study. Front Oncol. 2020;10:1408. doi: 10.3389/fonc.2020.01408.
  • Ding M, Ma S, Tang X, et al. Oliguric acute kidney injury after microwave ablation of large liver tumors: incidence and preventive measures. Int J Hyperthermia. 2019;35(1):141–149. doi: 10.1080/02656736.2018.1487589.
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. doi: 10.1159/000339789.
  • Tsai MC, Chang LT, Tam KW. Comparison of high-intensity focused ultrasound and conventional surgery for patients with uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(10):1712–1724. doi: 10.1016/j.jmig.2021.06.002.
  • Hinshaw JL, Lubner MG, Ziemlewicz TJ, et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation–what should you use and why? Radiographics. 2014;34(5):1344–1362. doi: 10.1148/rg.345140054.
  • Zhou W, Arellano RS. Thermal ablation of T1c renal cell carcinoma: a comparative assessment of technical performance, procedural outcome, and safety of microwave ablation, radiofrequency ablation, and cryoablation. J Vasc Interv Radiol. 2018;29(7):943–951. doi: 10.1016/j.jvir.2017.12.020.
  • Liu L, Wang T, Lei B. Ultrasound-guided microwave ablation in the management of symptomatic uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(12):1982–1992. doi: 10.1016/j.jmig.2021.06.020.
  • Lin XL, Hai N, Zhang J, et al. Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis. Int J Hyperthermia. 2020;37(1):151–156. doi: 10.1080/02656736.2019.1708481.
  • Ierardi AM, Petrillo M, Fumarola EM, et al. Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms. Minim Invasive Ther Allied Technol. 2021;30(1):33–39. doi: 10.1080/13645706.2019.1668417.
  • Zhang L, Zhang W, Orsi F, et al. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: a review of safety and efficacy. Int J Hyperthermia. 2015;31(3):280–284. doi: 10.3109/02656736.2014.996790.
  • Van Avondt K, Nur E, Zeerleder S. Mechanisms of haemolysis-induced kidney injury. Nat Rev Nephrol. 2019;15(11):671–692. doi: 10.1038/s41581-019-0181-0.
  • Deuel JW, Schaer CA, Boretti FS, et al. Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response. Cell Death Dis. 2016;7(1):e2064–e2064. doi: 10.1038/cddis.2015.392.
  • Graw JA, Hildebrandt P, Krannich A, et al. The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO. Crit Care. 2022;26(1):50. doi: 10.1186/s13054-022-03894-5.
  • Tang X, Ding M, Lu B, et al. Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomas. Int J Hyperthermia. 2019;36(1):632–639. doi: 10.1080/02656736.2019.1624837.